Study of a medication for stiff person syndrome
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests an intravenous (IV) medication called human normal immune globulin 10% to see if it helps reduce stiffness and spasms in adults with Stiff Person Syndrome (SPS). It might improve muscle symptoms and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 70 years old
- Have a formal diagnosis of Stiff Person Syndrome (SPS), with symptoms like stiffness or muscle spasms
- Have stiffness that mainly affects your torso and legs
- Be able to walk and move around (not bed-bound or wheelchair-dependent)
- Not have taken certain immune-suppressing drugs (like rituximab) or had botox injections within the last few months
- Be willing to visit the trial site for scheduled appointments and keep a daily diary
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called efgartigimod for stiff person syndrome, a rare autoimmune condition that causes muscle stiffness and spasms. The medicine may reduce the antibodies that attack the nervous system, which could help ease symptoms and improve daily function.
This trial tests whether a drug called Vyvgart (hyaluronidase-fjjo) can help people with stiff person syndrome who still have symptoms like stiffness, painful muscle spasms, and trouble walking despite other treatments. The goal is to see if it improves these symptoms and how well it works.
This study tests a new intravenous immunoglobulin (IVIG) treatment called KIg10 (QIVIGY) for people with chronic inflammatory demyelinating polyneuropathy (CIDP). It aims to see if this treatment can help manage symptoms and maintain stability.
This study tests an investigational drug (BMS-986368) to see if it helps reduce muscle stiffness and spasms caused by multiple sclerosis. It may be an option if you have had spasticity for at least 6 months and are not currently using other treatments that cannot be paused.
This study tests an investigational drug called KSVCBD for people with certain autoimmune diseases that haven't improved with standard treatments. It aims to see if the drug is safe and if it can help reduce symptoms.
This study tests an experimental pill (BMS-986368) that targets two brain chemicals to reduce muscle stiffness after a stroke. It's for people who had a stroke in the last 4 to 18 months and have moderate tightness in their elbow and wrist.
Hear when a new Stiff Person Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.